Last verified: 2026-05-03. Reviewed by Angelica Bottaro.
Known For: Founded in 2018 by board-certified psychiatrist Dr. Joshua Flatow as a full-service psychiatry group offering TMS alongside in-house ketamine therapy and pharmacogenomic testing; in-network with 15+ major insurers and offering Express and Accelerated TMS protocols.
| Location | San Francisco, California |
| Address | One Sansome Street, Ste 3500 San Francisco, CA 94104 |
| Phone | 310-571-5041 |
| Website | pacificmindhealth.com |
| Treatments | TMS therapy (transcranial magnetic stimulation) — BrainsWay Deep TMS |
| Protocols | Deep TMS |
| Conditions Treated | Treatment-resistant depression (TRD) · OCD · Anxious depression · Adolescent MDD (ages 15–21) · Smoking cessation |
| Insurance | Most major commercial plans, Medicare Part B, and Tricare typically cover TMS for treatment-resistant depression after prior authorization — verify with this clinic. |
| Cost | $300–500/session cash; $0–250/session typical insurance copay |
| Course | 36 sessions over 6–9 weeks (standard rTMS) |
HealingMaps Take: BrainsWay Deep TMS opens up OCD treatment on-label — a meaningful advantage over standard NeuroStar-only clinics, since only the H7 coil holds the FDA OCD clearance. Patients pursuing TMS for OCD or anxious depression should confirm the H7 coil specifically (vs the H1 coil used for MDD).
Market Position: One of the TMS providers in the San Francisco, CA metro offering Deep TMS — relevant for OCD seekers (only Deep TMS H7 holds the standalone FDA OCD clearance) and patients who want non-focal deeper coil penetration.
The TMS device a clinic operates determines which conditions can be treated on-label. The protocols offered here:
| Protocol | Session length | FDA-cleared for |
|---|---|---|
| Standard rTMS (10 Hz) | 19–37 min | TRD, anxious depression, adolescent MDD (15–21) |
| Deep TMS (H-coil) | ~20 min | TRD, OCD (H7), anxious depression, smoking cessation (H4) |
For a full breakdown of TMS devices (NeuroStar, BrainsWay, MagVenture, Magstim, Nexstim) and how protocols differ, see our complete guide to TMS therapy.
Cash-pay TMS sessions in San Francisco, CA typically run $300 to $500 per session, with the full 36-session course costing $7,200 to $15,000. Premium-metro clinics (NYC, San Francisco, Los Angeles, Boston) charge 30 to 50 percent more. With insurance, copays typically run $0 to $250 per session depending on your deductible status; most patients with employer-sponsored PPO plans pay $500 to $3,000 out-of-pocket for a full course. Many independent clinics offer 10 to 25 percent package discounts for cash-pay patients. TMS is HSA- and FSA-eligible. Contact this clinic directly for their specific cash-pay rates and in-network status with your insurer.
Most major commercial insurance plans (BCBS, Aetna, Cigna, UnitedHealthcare, Anthem, Humana), Medicare Part B, and Tricare cover TMS for treatment-resistant major depressive disorder. UnitedHealthcare typically requires 3 failed antidepressant trials; most other carriers require 2. Pre-authorization is mandatory across all major carriers. Coverage for off-label conditions (PTSD, fibromyalgia, bipolar depression, migraine) is rarely approved. Contact this clinic to verify in-network status with your specific insurer and to learn about their prior-authorization handling.
The “TMS dip” is a patient-coined term for temporary worsening of mood or symptom intensification that some patients experience roughly mid-course (commonly between sessions 10 and 20) before clinical improvement begins. It’s not a sign that TMS is failing — it usually resolves with continued treatment. If you experience the dip, tell your clinician immediately. They may adjust intensity, frequency, or coil position. Importantly, dropping out before session 20 substantially reduces overall response rate. Patients who push through the mid-course dip generally have better outcomes than those who quit early.
Yes. TMS requires no anesthesia, no sedation, and no IV access. Patients drive themselves to sessions, return to work, school, or normal activities immediately afterward, and need no chaperone or recovery period. This is the single largest patient-experience advantage TMS holds over ketamine therapy and ECT. Many patients schedule sessions on lunch breaks. The only post-session sensation is mild scalp tenderness for the first few sessions, which decreases substantially as scalp nerves desensitize.
This clinic operates BrainsWay Deep TMS. The device determines what conditions can be treated on-label. For OCD, only BrainsWay Deep TMS H7 has a standalone FDA clearance. For adolescents 15–21, only NeuroStar (since March 2024) and BrainsWay (since November 2025) hold the relevant indications. Ask the clinic which device they operate before booking.
Possibly — but only BrainsWay Deep TMS using the H7 coil holds a standalone FDA clearance for OCD (granted via the De Novo pathway in 2018). MagVenture’s Cool D-B80 has an OCD adjunct clearance. Standard NeuroStar (figure-8 coil) is not FDA-cleared for OCD. This clinic appears to use BrainsWay Deep TMS, which is the FDA-cleared device for OCD. The full OCD course is 29 sessions over 6 weeks with symptom-provocation protocols.
The FDA has cleared TMS for adolescents 15 to 21 with major depressive disorder. NeuroStar received the first adolescent clearance in March 2024; BrainsWay Deep TMS followed in November 2025. There is no current FDA clearance for ages 12 through 14. Real-world evidence from NeuroStar’s clearance documentation cited 78 percent of treated adolescents achieving clinically meaningful improvement. Contact this clinic to confirm whether their device holds the adolescent indication and whether they treat patients in this age range.

Pacific Mind Health San Francisco offers transcranial magnetic stimulation (TMS) therapy to people with various mood disorders. By doing so, they can help people overcome conditions that have failed to be eased with traditional forms of treatment. Conditions that can be treated using TMS therapy include depression, anxiety, post-traumatic stress disorder and more.
⚠ FDA-cleared indications for TMS therapy: treatment-resistant major depressive disorder (MDD), obsessive-compulsive disorder (OCD, Deep TMS only), anxious depression, short-term smoking cessation, and adolescent MDD (ages 15–21). Use of TMS for other conditions including PTSD, bipolar depression, fibromyalgia, and other indications is off-label — not currently FDA-cleared for those specific indications. Discuss your condition with the clinic to understand insurance coverage and clinical evidence.
When choosing a mental health care provider, feedback from past and current clients is invaluable. At Pacific Mind Health in San Francisco, client satisfaction is a top priority. Here’s what people appreciate about their services:
Each of these factors contributes to the high regard in which Pacific Mind Health is held among those seeking mental health services in San Francisco.
While we delve deep into the many positives, it’s crucial to address the concerns some have expressed about Pacific Mind Health in San Francisco. Our commitment to transparency drives us to shed light on these aspects, ensuring you get a comprehensive view. Here are some points of contention highlighted by clients:
The highly-skilled support staff at Pacific Mind Health San Francisco is led by board-certified psychiatrist Dr. Joshua Flatow. He and his team offer the most modern forms of treatment in a warm and welcoming environment. By providing TMS therapy, the clinic hopes to help as many people as possible regain control over their lives. People looking for ketamine therapy at the clinic can fill out their online TMS therapy assessment form.
RELATED: The Best TMS Clinics in Los Angeles, California
Discover more Pacific Mind Clinic locations
Leave a Reply